Episode 64: “We Pass on 98.5%” | Bio Angels Yaniv Sneor and Alex Pederson on Life Science Angel Investing, Screening Criteria, and Exit Discipline
About this episode
This episode discusses life science angel investing and the screening criteria used by Mid Atlantic Bio Angels.
🗞️ Get essential angel intel straight to your inbox every week with The Diligent Observer Newsletter. 🗞️ Today's episode explores three ideas that caught my attention: ① Disciplined screening can be tested: Yaniv and Alex explain how Mid Atlantic Bio Angels reviewed more than a decade of life science startup applications to ask whether the group’s screening criteria were helping or causing them to miss the winners. ② Life science angel investing has different economics: In therapeutics, medic...
More episodes of The Diligent Observer Podcast
- Episode 68: "Dual Use Isn’t a Distraction" | 757 Collab President & CEO Paul Nolde on Dual-Use Startups
- Episode 67: Charlotte Angel Fund Administrator Greg Brown On Why a $50M Exit Might Not Be Enough
- Replay: Episode 19: "Smart Money Goes Beyond the Checkbook" | Seasoned Angel Investor Mitra Miller on the Importance of Founder "Relentlessness", Innovation in Houston, and "Poker" vs "Roulette"
- Episode 66: “Build vs Buy” | Black Prism Capital Partners Founder Steven Miller on Dual-Use Investing, Government Sales, and Deep Tech Diligence
- Episode 65: Faith Driven Angel Investing | Will Thomas, Co-Founder of Ambassadors Impact Network
Explore listener stats, chart rankings, contacts and more on the The Diligent Observer Podcast podcast page.